REG - Patria Pvt Eq Trust. - Appointment of Non-executive Director

Patria Private Equity TrustAnnouncement

21/01/2025 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250121:nRSU1663Ua&default-theme=true

RNS Number : 1663U  Patria Private Equity Trust PLC  21 January 2025

Patria Private Equity Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

21 January 2025

Appointment of Non-executive Director

The Board of Patria Private Equity Trust plc ("the Company") is pleased to
announce the appointment of Duncan Budge as an additional independent
Non-executive Director with effect from 1 February 2025.

Diane Seymour-Williams, the Chair of the Nomination Committee, said "The Board
regularly considers succession planning and is delighted that Duncan has
agreed to join our Board.  Duncan brings a wealth of experience having worked
with investment companies during his executive and non-executive career and
the Board looks forward to working with him."

Duncan retired from his role as an Executive Director and Chief Operating
Officer of RIT Capital Partners plc in 2011, having been appointed in 1995.
He is a Non-executive Director of Lowland Investment Company plc, Biopharma
Credit plc and Asset Value Investors Ltd.  He was until recently Chair of
Artemis Alpha Trust plc and Dunedin Enterprise Investment Trust plc.

There are no other disclosures required under Section 9.6.13 (1) to (6) of the
Listing Rules in respect of Duncan's appointments.

 

For further information, please contact:

 

Paul Evitt

GPMS Corporate Secretary Limited

paul.evitt@patria.com (mailto:paul.evitt@patria.com)

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPPUQCGUPAGCG